Stipple Bio
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
238 Main St, Cambridge, Massachusetts, 0...Website
stipple.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Stipple Bio
Stipple Bio is a privately held biotechnology company based in Cambridge, Massachusetts, USA that develops advanced cellular profiling and target discovery technologies with epitopelevel resolution to accelerate drug discovery, particularly in precision oncology. Its proprietary Pointillist platform identifies tumorspecific epitopes on cell surfaces, enabling the development of targeted therapeutics such as nextgeneration antibodydrug conjugates and other cancer interventions. The company completed a significant SeriesA financing led by top lifescience investors to support clinical studies of its lead oncology candidates and expand its pipeline.Stipple Bio is viewed as part of the emerging precision medicine and biotherapeutics ecosystem, combining highresolution biological data with innovative discovery platforms to address unmet needs in cancer treatment.Explore more
Stipple Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stipple Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Stipple Bio has recently received funding, and reach out quickly before it becomes old news!
Stipple Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Stipple Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Stipple Bio
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Stipple Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Stipple Bio recently announced quarterly report
Check out if Stipple Bio is spiking on competitors!
Funding: Get notified immidiatlly once Stipple Bio has new funding data
Recommended Actions
Reach out to Masked Content who joined Stipple Bio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Stipple Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Stipple Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Stipple Bio.
Stipple Bio financials insights
Gather financial insights about Stipple Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Seed
$12M
2026
Series A
$100M
Stipple Bio Tech Stack
A closer look at the technologies used by Stipple Bio
Stipple Bio News & Media
Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies
– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform —
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Stipple Bio
Sign Up For FreeTo access detailed company insights
Stipple Bio is a privately held biotechnology company based in Cambridge, Massachusetts, USA that develops advanced cellular profiling and target discovery technologies with epitopelevel resolution to accelerate drug discovery, particularly in precision oncology. Its proprietary Pointillist platform identifies tumorspecific epitopes on cell surface... Read More
